Cyberonics Announces Peer-Reviewed Publication Of VNS Therapy® Long-Term Comparative Effectiveness Study In Patients With Refractory Epilepsy
PR Newswire - Tue May 06, 8:00AM CDT
Cyberonics, Inc. (NASDAQ:CYBX) today announced positive results from the PuLsE (Open Prospective Randomized Long-term Effectiveness) study conducted at 28 sites in Europe and Canada and published in the peer-reviewed journal Epilepsia.
3 Stocks Breaking Out on Big Volume
at The Street - Mon May 05, 8:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Product Launches, Conference Call Schedules, Promotions, and Appointments - Analyst Notes on Theravance, Volcano, Steris, Cyberonics and Kythera
PR Newswire - Thu May 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Theravance Inc. (NASDAQ: THRX), Volcano Corporation (NASDAQ: VOLC), Steris Corp. (NYSE: STE), Cyberonics Inc. (NASDAQ: CYBX) and Kythera Biopharmaceuticals, Inc. (NASDAQ: KYTH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1881-100free.
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
PR Newswire - Mon Apr 28, 8:00AM CDT
Cyberonics, Inc. (NASDAQ:CYBX) today announced the promotion of Rohan Hoare, Ph.D., to the newly created role of Chief Operating Officer. As COO, Rohan will be responsible for the development, manufacturing, quality and commercial activities for the Epilepsy franchise. The company also announced that O'Neill F. D'Cruz, M.D. recently joined the company as Chief Medical Officer.
Weakness Seen in AngioDynamics (ANGO): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 7:43AM CDT
AngioDynamics falls 7.8% last trading session, continuing the downtrend
Insider Trading Alert - APA, DDS And CYBX Traded By Insiders
at The Street - Thu Apr 10, 11:02AM CDT
Stocks with insider trader activity include APA, DDS and CYBX
Insider Trading Alert - AEIS, CYBX And IR Traded By Insiders
at The Street - Fri Apr 04, 10:15AM CDT
Stocks with insider trader activity include AEIS, CYBX and IR
Intuitive Surgical (ISRG) in Focus: Stock Rises 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 8:25AM CDT
Intuitive Surgical was a big mover last session, with shares rising nearly 13% on the day.
Balanced View on Haemonetics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 1:50PM CDT
On Mar 28, we issued an updated research report on Haemonetics Corporation.
Balanced View on Hologic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 1:50PM CDT
On Mar 27, we issued an updated research report on Hologic.
FDA Clears Volcano Corp's iFR Modality - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 4:10PM CDT
Volcano Corporation recently received the U.S. FDA approval for the company's proprietary iFR (instant wave-Free Ratio) Modality.
Insider Trading Alert - ACMP, CYBX And HSIC Traded By Insiders
at The Street - Wed Mar 19, 10:00AM CDT
Stocks with insider trader activity include ACMP, CYBX and HSIC
Techne Downgraded to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 2:30PM CDT
Techne has witnessed sharp downward estimate revisions after reporting its second-quarter fiscal 2014 results.
Insider Trading Alert - VRSN, TUP And CYBX Traded By Insiders
at The Street - Fri Mar 07, 10:00AM CST
Stocks with insider trader activity include VRSN, TUP and CYBX
Insider Trading Alert - IP, CYBX And JAZZ Traded By Insiders
at The Street - Thu Mar 06, 1:00PM CST
Stocks with insider trader activity include IP, CYBX and JAZZ
Cyberonics Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 2:10PM CST
On Feb 26, 2014, Zacks Investment Research upgraded Cyberonics Inc. to a Zacks Rank #2 (Buy).
Cyberonics Q3 sales short
at Investor's Business Daily - Thu Feb 20, 6:14PM CST
Implantable medical device maker Cyberonics (CYBX) said fiscal Q3 earnings per share rose 9% compared to a year ago, to 51 cents, beating analyst estimates by 2 cents. Revenue also rose 9% to $68.2 mil, just missing views for $69.7 mil. The company...
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy®
PR Newswire - Thu Feb 20, 6:15AM CST
Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator.
Cyberonics Reports Fiscal 2014 Third Quarter Results
PR Newswire - Thu Feb 20, 6:00AM CST
Cyberonics, Inc. (NASDAQ:CYBX) today announced results for the quarter, and year-to-date, ended January 24, 2014.
Cyberonics To Participate In Upcoming Investor Conferences
PR Newswire - Wed Feb 19, 3:00PM CST
Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.